Literature DB >> 1370084

Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.

M Matsuda1, C T Reichman, H Hanafusa.   

Abstract

The chicken CT10 virus oncogene product, P47gag-crk, contains SH2/SH3 domains that have been identified as conserved domains among proteins involved in signal transduction. We studied the functional similarity of the SH2/SH3 domains by replacing those of v-Crk with those of phosphatidylinositol-specific phospholipase C-gamma, v-Src, or c-Src. The transforming activity of v-Crk was partially retained in a mutant with a v-Src SH3 domain but not in the other mutants with heterologous SH2/SH3 domains. Mutant viruses with Crk-SH2/SH2' domains induced tyrosine phosphorylation of cellular proteins, but mutants with phosphatidylinositol-specific phospholipase C-gamma or Src SH2/SH2' domains did not. However, the mutant proteins with heterologous SH2/SH2' regions were able to weakly associate with some phosphotyrosine-containing proteins in vitro. These results indicate that in the context of the P47gag-crk structure, the requirement of Crk-SH2/SH3 is more stringent for its activity to induce cell transformation than to cause phosphorylation of cellular proteins. The substitution with heterologous sequences least perturbs the capacity to bind phosphotyrosine-containing proteins. In each case, the SH3 domain is more flexible to substitution than is the SH2 domain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370084      PMCID: PMC238266     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Nck, a melanoma cDNA encoding a cytoplasmic protein consisting of the src homology units SH2 and SH3.

Authors:  J M Lehmann; G Riethmüller; J P Johnson
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

3.  Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.

Authors:  B J Mayer; H Hanafusa
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 5.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

6.  Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors.

Authors:  D Anderson; C A Koch; L Grey; C Ellis; M F Moran; T Pawson
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

7.  Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.

Authors:  B J Mayer; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.

Authors:  P C Espino; R Harvey; R L Schweickhardt; G A White; A E Smith; S H Cheng
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

9.  Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; H Hanafusa
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.

Authors:  P Jackson; D Baltimore
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  12 in total

1.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.

Authors:  T Akagi; T Shishido; K Murata; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

3.  Two species of human CRK cDNA encode proteins with distinct biological activities.

Authors:  M Matsuda; S Tanaka; S Nagata; A Kojima; T Kurata; M Shibuya
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

4.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.

Authors:  S Tanaka; S Hattori; T Kurata; K Nagashima; Y Fukui; S Nakamura; M Matsuda
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.

Authors:  J E Fajardo; R B Birge; H Hanafusa
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment.

Authors:  J Meisenhelder; T Hunter
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

9.  p104 binds to Rac1 and reduces its activity during myotube differentiation of C2C12 cell.

Authors:  Ki Young Choi; Min Sup Lee; Young Jun Cho; Myong Ho Jeong; Seung Jin Han; Seung Hwan Hong
Journal:  ScientificWorldJournal       Date:  2014-01-23

10.  c-Abl kinase regulates the protein binding activity of c-Crk.

Authors:  S M Feller; B Knudsen; H Hanafusa
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.